Lejie, Cao
63  results:
Search for persons X
?
2

Patient-reported outcomes for the phase 3 FURLONG study of ..:

Shi, Yuankai ; Chen, Gongyan ; Wang, Xiang...
The Lancet Regional Health - Western Pacific.  48 (2024)  - p. 101122 , 2024
 
?
 
?
 
?
 
?
10

Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3..:

Lu, Shun ; Pan, Hongming ; Wu, Lin...
Signal Transduction and Targeted Therapy.  8 (2023)  1 - p. , 2023
 
?
11

Envonalkib versus crizotinib for treatment-naive ALK-positi..:

Yang, Yunpeng ; Min, Jie ; Yang, Nong...
Signal Transduction and Targeted Therapy.  8 (2023)  1 - p. , 2023
 
?
12

Central Nervous System Efficacy of Furmonertinib (AST2818) ..:

Shi, Yuankai ; Chen, Gongyan ; Wang, Xiang...
Journal of Thoracic Oncology.  17 (2022)  11 - p. 1297-1305 , 2022
 
?
13

Long-Term Efficacy, Safety, and Subgroup Analysis of Savoli..:

Lu, Shun ; Fang, Jian ; Li, Xingya...
JTO Clinical and Research Reports.  3 (2022)  10 - p. 100407 , 2022
 
1-15